3 ms·
> The 5-year survival rate for cancers is much better in the US than Europe. It's what you'd expect for all the money spent, whether it is worth it is unclear.
by tzs 9y ago
> The 5-year survival rate for cancers is much better in the US than Europe. It's what you'd expect for all the money spent, whether it is worth it is unclear.
Note that survival rate is measured from when the cancer is diagnosed. For many of those cancers the US screens for them more frequently than they do in the rest of the world.
If Alice and Bob both get cancer in 2015 which will kill them in 2021, and Alice lives in a place where they screen for it every year she will survive for 5 years after diagnoses. If Bob lives someplace where they only screen every 4 years and he was last screened in 2014 he will only survive 3 years after diagnoses. Same cancer, same outcome in the same number of years, but Alice counts as a 5 year survivor and Bob does not.
Another thing to watch out for when comparing health systems across countries is different definitions. For instance the US generally has a higher infant mortality rate than other western countries, but at least part of that is because of different definitions.
For example, a very premature baby with very low birth weight has essentially no chance of survival. In much of the world this would be counted as a stillbirth. In much of the US, however, if it was not actually dead at birth it will be counted as a live birth. Result: a few minutes or hours later, when it actually dies, it is infant mortality in the US statistics and not infant mortality elsewhere.
(These definitional differences are not enough to explain the higher infant mortality in the US, but they do close the gap a bit).
- WillPostForFood 9y agoAgree with all you've said, and your point about more screening in the US is another reason costs are higher. Both because more screenings cost more money, and the more stuff you find, the more costly interventions it leads to.